UK markets open in 3 hours 22 minutes
NIKKEI 225
38,329.39 +777.23 (+2.07%) HANG SENG
17,118.81 +289.88 (+1.72%) CRUDE OIL
83.40 +0.04 (+0.05%) GOLD FUTURES
2,338.50 -3.60 (-0.15%) DOW
38,503.69 +263.71 (+0.69%) Bitcoin GBP
53,492.50 +3.85 (+0.01%)
CRISPR Therapeutics AG (CRSP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 4.79B |
| Enterprise value | 3.33B |
| Trailing P/E | 124.34 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 12.08 |
| Price/book (mrq) | 2.54 |
| Enterprise value/revenue | 9.01 |
| Enterprise value/EBITDA | -16.44 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.74 |
| 52-week change 3 | 15.95% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 91.10 |
| 52-week low 3 | 37.55 |
| 50-day moving average 3 | 72.19 |
| 200-day moving average 3 | 59.51 |
Share statistics
| Avg vol (3-month) 3 | 1.75M |
| Avg vol (10-day) 3 | 1.39M |
| Shares outstanding 5 | 84.88M |
| Implied shares outstanding 6 | 84.88M |
| Float 8 | 78.84M |
| % held by insiders 1 | 1.86% |
| % held by institutions 1 | 69.17% |
| Shares short (28 Mar 2024) 4 | 14.76M |
| Short ratio (28 Mar 2024) 4 | 10.24 |
| Short % of float (28 Mar 2024) 4 | 18.63% |
| Short % of shares outstanding (28 Mar 2024) 4 | 18.38% |
| Shares short (prior month 29 Feb 2024) 4 | 15.06M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -41.38% |
| Operating margin (ttm) | 34.58% |
Management effectiveness
| Return on assets (ttm) | -6.22% |
| Return on equity (ttm) | -8.17% |
Income statement
| Revenue (ttm) | 371.21M |
| Revenue per share (ttm) | 4.69 |
| Quarterly revenue growth (yoy) | 3,353,333.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -202.7M |
| Net income avi to common (ttm) | -153.61M |
| Diluted EPS (ttm) | -1.94 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.69B |
| Total cash per share (mrq) | 21.1 |
| Total debt (mrq) | 238.63M |
| Total debt/equity (mrq) | 12.67% |
| Current ratio (mrq) | 17.54 |
| Book value per share (mrq) | 23.52 |
Cash flow statement
| Operating cash flow (ttm) | -260.38M |
| Levered free cash flow (ttm) | -238.97M |
© 2024 Yahoo. All rights reserved.